ST
CVS icon

Sabal Trust’s CVS Health CVS Stock Holding History

Sabal Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,087
Closed -$383K – 235
2024
Q3 		$383K Buy
+6,087
New +$355K 0.02% 179
2024
Q2 		– Sell
-2,622
Closed -$209K – 215
2024
Q1 		$209K Sell
2,622
-602
-19% -$46K 0.01% 211
2023
Q4 		$255K Buy
+3,224
New +$229K 0.02% 197
2023
Q1 		– Sell
-6,210
Closed -$579K – 154
2022
Q4 		$579K Sell
6,210
-94
-1% -$9.07K 0.04% 91
2022
Q3 		$601K Buy
6,304
+60
+1% +$5.94K 0.05% 91
2022
Q2 		$579K Buy
6,244
+4,075
+188% +$398K 0.04% 91
2022
Q1 		$219K Buy
+2,169
New +$228K 0.02% 132
2018
Q2 		– Sell
-4,924
Closed -$307K – 141
2018
Q1 		$307K Buy
+4,924
New +$353K 0.03% 129
2017
Q4 		– Sell
-293,347
Closed -$23.9M – 135
2017
Q3 		$23.9M Buy
293,347
+19,916
+7% +$1.58M 2.38% 27
2017
Q2 		$22M Buy
273,431
+16,526
+6% +$1.3M 2.31% 30
2017
Q1 		$20.2M Buy
+256,905
New +$20.5M 2.25% 31

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sabal Trust's CVS Position: Q4 2024 in Review

Sabal Trust sold out of CVS Health (CVS) in Q4 2024, closing a stake of 6,087 shares — an estimated $383K sold.

Sabal Trust first reported a position in CVS in Q1 2017 and held it in 11 quarters. The position peaked at $23.9M in Q3 2017. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Sabal Trust reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Sabal Trust sold 6,087 CVS Health shares in Q4 2024, an estimated $383K.
  • Sabal Trust first reported a position in CVS Health in Q1 2017 and held it in 11 quarters.
  • Sabal Trust's CVS Health position peaked at $23.9M in Q3 2017.
  • 1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Sabal Trust's 13F filing for Q4 2024, filed 5 Feb 2025.